GLOSSARY

Phosphoinositide 3-Kinase (PI3K) is a lipid kinase producing membrane-associated signals.

Membrane receptors can signal through G proteins, kinase activity or associated pathways; intracellular receptors often connect to gene regulation. A second messenger is distinct from the hormone, and one signal can engage several branches. Rapid responses and longer-term expression changes are not equivalent. A pathway's name alone cannot establish the actual magnitude of its effect on muscle, appetite or energy storage without tissue and outcome information.

Sensitivity is response to a given signal and is not identical to hormone concentration or receptor number. Receptor abundance, binding and downstream signaling can each alter response. Maximum responsiveness also differs from a shift in sensitivity. One blood value cannot describe all tissue receptors; assay type and target tissue are needed to interpret resistance or sensitivity rather than treating these as directly interchangeable concentration measurements.

AMPK, mTOR and related pathways integrate energy, amino-acid and other information; these proteins are not circulating hormones themselves. Components have different roles and tissue-dependent responses. A brief rise in an anabolic marker is not equivalent to guaranteed muscle gain. Effective training, adequate energy and protein and recovery opportunity are needed alongside molecular signaling for real outcomes rather than judging success from pathway activation alone.

Hormonal axes use feedback and often pulsatile and time-dependent patterns. A rise can be compensatory and a decline temporarily adaptive, neither diagnosing disease without context. Hormone ratios depend on numerator, denominator, timing and units. Sports nutrition does not aim to maximize every hormone; the practical goal is adequate supply and appropriate physiological responses, evaluated with health and performance rather than an isolated ratio or peak.

Exercise mode, intensity, duration, recruited muscle, training history and prior food influence hormonal responses. Acute changes differ from baseline adaptations after training. Higher concentration does not necessarily mean greater secretion or tissue effect, because clearance, plasma volume and receptors also matter. Performance develops through combined adaptations, so targeting a hormone peak is not sufficient for session design or supplement selection; actual recovery and performance must remain part of evaluation.

Hormonal imbalance is a broad description rather than a standalone diagnosis from an online symptom list. Deficiency, excess and resistance differ, and reference ranges depend on method, age and conditions. Medicines, illness, sleep and energy status also matter. Persistent symptoms need appropriate assessment to identify causes; choosing supplements or manipulating hormones from one isolated test cannot replace evidence-based evaluation or establish a universal athletic hormone target.